TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT06702475

Intervention type: DIAGNOSTIC_TEST
Intervention: Home Sleep Test with Watch PAT-one
Description: Each participant will have a Watch-PAT one home sleep test, recording pulse oximetry, pulse tonometry, wrist actigraphy, snoring (by microphone), and chest motion by accelerometer.

Intervention type: DIAGNOSTIC_TEST
Intervention: Home Sleep Test with Watch PAT-one
Description: Each participant will have a Watch-PAT one home sleep test, recording pulse oximetry, pulse tonometry, wrist actigraphy, snoring (by microphone), and chest motion by accelerometer.

Intervention type: DIAGNOSTIC_TEST
Intervention: Home Sleep Test with Watch PAT-one
Description: Each participant will have a Watch-PAT one home sleep test, recording pulse oximetry, pulse tonometry, wrist actigraphy, snoring (by microphone), and chest motion by accelerometer.
Study: NCT06703671

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: electroacupuncture group
Description: According to the acupuncture prescription, the acupuncture doctor carried out acupuncture and lifting and twisting, and qi appeared under the needle. Select waist Jiaji point and Shenshu point on the same side to connect a set of electronic needle therapy instrument, the positive pole (red clip) connected to Shenshu point, the negative pole (white clip) connected to waist Jiaji point, after confirming that the electric current intensity of the electric needle instrument returns to zero, open the electronic needle therapy instrument, select continuous wave, 2Hz, current intensity 2mA. During the process of needle retention, the other points were injected every 15 minutes and retained for 30 minutes.The investigators have developed detailed acupoint positioning and operation rules.

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: sham-acupuncture group
Description: The investigators fixed the foam pad with one hand and inserted a comfort needle with the other, making sure the needle only touched the surface of the skin and did not penetrate the point. After the completion of all acupoint operations, the operator selected the simulated needle insertion points of Jiaji point on the waist and Shenshu point on the same side. An electroacupuncture treatment device designed to connect a circuit interrupt treatment is operated with the electroacupuncture group, a process that ensures that the participant does not experience any perceptible stimulation
Study: NCT06703593

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Alpha lipoic acid
Description: ALA effectively inhibits nuclear factor-kappa B with subsequent decreasing proinflammatory cytokines production (TNF-α, IL-6) and increasing the release of anti- inflammatory cytokines such as interleukin-10 (Haghighatdoost and Hariri, 2019). Relying on the antioxidant and anti-inflammatory effect of Alpha lipoic acid confirmed by a variety of studies in vitro and in vivo, ALA is selected to be studied in Egyptian breast cancer patients who will be treated with doxorubicin including regimens.
Study: NCT06703151

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: CMDs (Cardiometabolic Diseases) Self-Care Manual
Description: 1st-5th month: Complete the assessment of self-care ability and biochemical indicators, introduce the (CMDs self-care) teaching material manual, and evaluate the case's referral treatment status from the institution, and provide answers to questions. Played the Monopoly board game 8 times: On average, each community has about 2-3 groups (a group of 4-7 people), each group has a leader (seed teacher) to conduct CMDs health education Q\&A before each board game activity . 6th month: Conduct self-care process assessment in each community. 7th-12th month: Telephone visits are provided every 2 months (3 times in total), each case lasts 5-10 minutes each time.
Study: NCT06024785

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Vertebropexy
Description: microsurgical (i.e., the use of a microscope or magnifying glasses during decompression) lumbar laminotomy with partial removal of the medial facet joint by preserving the midline structures (supraspinous-interspinous ligament complex); approach: bilateral or ipsilateral with cross-over to the contralateral side. Additional stabilization of the spine with a ligament (for instance semitendinosus donor allograft), which connect the postoprior structures (Proc. Spinosus and/or Lamina) of the vertebrae . Situation-related application of laminar bands or analogous suture material (for instance FiberTape, Arthrex, Naples or Nile Band, K2M, Virginia)

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Vertebropexy
Description: microsurgical (i.e., the use of a microscope or magnifying glasses during decompression) lumbar laminotomy with partial removal of the medial facet joint by preserving the midline structures (supraspinous-interspinous ligament complex); approach: bilateral or ipsilateral with cross-over to the contralateral side. Additional stabilization of the spine with a ligament (for instance semitendinosus donor allograft), which connect the postoprior structures (Proc. Spinosus and/or Lamina) of the vertebrae . Situation-related application of laminar bands or analogous suture material (for instance FiberTape, Arthrex, Naples or Nile Band, K2M, Virginia)

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Vertebropexy
Description: microsurgical (i.e., the use of a microscope or magnifying glasses during decompression) lumbar laminotomy with partial removal of the medial facet joint by preserving the midline structures (supraspinous-interspinous ligament complex); approach: bilateral or ipsilateral with cross-over to the contralateral side. Additional stabilization of the spine with a ligament (for instance semitendinosus donor allograft), which connect the postoprior structures (Proc. Spinosus and/or Lamina) of the vertebrae . Situation-related application of laminar bands or analogous suture material (for instance FiberTape, Arthrex, Naples or Nile Band, K2M, Virginia)

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Vertebropexy
Description: microsurgical (i.e., the use of a microscope or magnifying glasses during decompression) lumbar laminotomy with partial removal of the medial facet joint by preserving the midline structures (supraspinous-interspinous ligament complex); approach: bilateral or ipsilateral with cross-over to the contralateral side. Additional stabilization of the spine with a ligament (for instance semitendinosus donor allograft), which connect the postoprior structures (Proc. Spinosus and/or Lamina) of the vertebrae . Situation-related application of laminar bands or analogous suture material (for instance FiberTape, Arthrex, Naples or Nile Band, K2M, Virginia)
Study: NCT06038916

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: STSA-1002 Injection Placebo
Description: Intravenous infusion

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: STSA-1002 Injection Placebo
Description: Intravenous infusion

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: STSA-1002 Injection
Description: Intravenous infusion

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: STSA-1002 Injection
Description: Intravenous infusion
Study: NCT04751253

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: High Intensity Laser Therapy
Description: different doses of energies of high-intensity LASER on pain and functional activity in patients with chronic knee OA.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: High Intensity Laser Therapy
Description: different doses of energies of high-intensity LASER on pain and functional activity in patients with chronic knee OA.

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: High Intensity Laser Therapy
Description: different doses of energies of high-intensity LASER on pain and functional activity in patients with chronic knee OA.
Study: NCT06309771

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Stress management, sleep improvement and fatigue reduction, sedentary behaviors reduction and physical activity promotion.
Description: The study seeks to quantify the impact of a complex intervention based on 3 modules :~1. Stress management~2. Sleep improvement and fatigue reduction,~3. Sedentary behaviors reduction and physical activity promotion.~Students from the interventional group will follow these 3 different health-related modules in a random order (6 predetermined order). Each module will be composed on 3 sessions. Each session includes individual interviews covering initial assessment and personalized goal setting.
Study: NCT06337929

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: CAPOEIRA TRAINING
Description: The protocol of the capoeira training program and the movements (blows, dodges and flourishes) will be based on the Capoeira Abadá method.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: CONTROL GROUP
Description: The protocol of the control group will be based on an intervention with capoeira movements, however, without important cardiovascular, neuromuscular and metabolic demands, being an activity with stretching movements from positions of the capoeira modality itself.
Study: NCT05718622

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: real EECP
Description: Real EECP treatment is delivered 45min per day for 14 sessions continuously. The treatment pressure sets at 150 millimeters of mercury.

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: sham EECP
Description: Sham EECP treatment is delivered 45min per day for 14 sessions continuously. The treatment pressure sets at 75 millimeters of mercury.
Study: NCT05746338

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Ring-type wearable device
Description: The ring-type wearable device is a slim, lightweight smart ring that continuously tracks blood oxygen saturation and heart rate throughout the day.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Overnight polysomnography
Description: Overnight polysomnography is the gold standard for diagnosing OSAS.
Study: NCT05851976

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Naproxen
Description: Naproxen 500mg twice daily for 16 days

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Naproxen
Description: Naproxen 500mg twice daily for 16 days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Duloxetine
Description: Duloxetine 60mg daily for 14 days
Study: NCT05292079

Intervention type: DEVICE
Intervention: CAPTURER
Description: Patients in whom treatment with (CAPTURER) has been attempted
Study: NCT05995964

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PF-07275315
Description: subcutaneous injection

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PF-07275315
Description: subcutaneous injection

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PF-07275315
Description: subcutaneous injection

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PF-07275315
Description: subcutaneous injection

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PF-07275315
Description: subcutaneous injection

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PF-07264660
Description: subcutaneous injection

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PF-07264660
Description: subcutaneous injection

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PF-07264660
Description: subcutaneous injection
Study: NCT05750121

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: E-health enhanced motor-cognitive training
Description: The intervention group will implement physical activity (aerobic exercise and resistance training) and cognitive training (CogniFit) intervention with the e-health components (persuasive technology). The intervention period will last for 12 weeks, with three 90 minutes sessions (60 minutes of physical activity and 30 minutes of cognitive training) per week.
Study: NCT04566744

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: fRMI
Description: The measurements performed will be the participant's brain activity, as well as behavioral measurements associated with the tasks performed (response time, correctness of the response). Brain activity measurements will be performed on the Siemens 3T system of the MRI department of CERMEP. The subject will perform the task under study while the level of brain activity is recorded. The functional examination will be subdivided into several parts according to its total length in order to spare the subject. The total duration of MRI acquisitions will be approximately 1 hour regardless of the axis.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: fRMI
Description: The measurements performed will be the participant's brain activity, as well as behavioral measurements associated with the tasks performed (response time, correctness of the response). Brain activity measurements will be performed on the Siemens 3T system of the MRI department of CERMEP. The subject will perform the task under study while the level of brain activity is recorded. The functional examination will be subdivided into several parts according to its total length in order to spare the subject. The total duration of MRI acquisitions will be approximately 1 hour regardless of the axis.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: fRMI
Description: The measurements performed will be the participant's brain activity, as well as behavioral measurements associated with the tasks performed (response time, correctness of the response). Brain activity measurements will be performed on the Siemens 3T system of the MRI department of CERMEP. The subject will perform the task under study while the level of brain activity is recorded. The functional examination will be subdivided into several parts according to its total length in order to spare the subject. The total duration of MRI acquisitions will be approximately 1 hour regardless of the axis.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: fRMI
Description: The measurements performed will be the participant's brain activity, as well as behavioral measurements associated with the tasks performed (response time, correctness of the response). Brain activity measurements will be performed on the Siemens 3T system of the MRI department of CERMEP. The subject will perform the task under study while the level of brain activity is recorded. The functional examination will be subdivided into several parts according to its total length in order to spare the subject. The total duration of MRI acquisitions will be approximately 1 hour regardless of the axis.
Study: NCT05788406

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Short foot exercises, Dynamic balance exercises and insole
Description: Short foot exercises is used to improve muscle strenght, Dynamic balance exercises is used to improve balance and insole is used to improve MLA

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Short foot exercises, Dynamic balance exercises and insole
Description: Short foot exercises is used to improve muscle strenght, Dynamic balance exercises is used to improve balance and insole is used to improve MLA

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Short foot exercises, Dynamic balance exercises and insole
Description: Short foot exercises is used to improve muscle strenght, Dynamic balance exercises is used to improve balance and insole is used to improve MLA
Study: NCT05903573

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive Training
Description: The intervention group will receive cognitive training that provides specific training tasks directed at essential cognitive domains tied to the project's aims and hypotheses (processing speed and working memory) that correspond with the neurocognitive and functional neuroimaging measures to be studied.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Computerized Cognitive Stimulation
Description: Participants will complete cognitively-stimulating computer activities. The duration is 60 min/day; the frequency is two to three days/wk, for 16 weeks with the goal of completing 40 sessions.
Study: NCT06361914

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Digital CBT-I
Description: Sleep restriction includes behavioral instructions to limit the time spent in bed to increase sleep drive and further reduce time awake in bed.~Stimulus control therapy entails behavioral instructions to strengthen the association between bed and sleep and to eliminate conditioning of non-sleep behavior and bed.~Deactivation/relaxation training involves methods to reduce somatic tension and limit intrusive thought processes that interfere with sleep.~Cognitive therapy helps to identify, challenge, and modify dysfunctional beliefs about sleep.~Sleep hygiene education entails specific information relating to lifestyle and environmental factors that may interfere with or promote sound sleep. Sleep hygiene education also includes specific sleep facilitating recommendations, such as avoiding visual access to a clock in the bedroom, regular sleep scheduling, avoiding long daytime naps, and limiting alcohol, caffeine, and nicotine intake.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Digital Sleep hygiene education
Description: Sleep hygiene education entails specific information relating to lifestyle (diet, exercise, substance use) and environmental factors (light, noise, temperature) that may interfere with or promote sound sleep. Sleep hygiene education also includes specific sleep facilitating recommendations, such as avoiding visual access to a clock in the bedroom, regular sleep scheduling, avoiding long daytime naps, and limiting alcohol, caffeine, and nicotine intake.
Study: NCT05118308

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Transjugular hepatic venous pressure gradient measurement with liver biopsy
Description: This procedure will be performed by an experienced interventional radiologist who will be supported by a radiology technician and nurse. Transjugular hepatic venous pressure gradient measurement will be performed using standard procedure. Following this, a transjugular liver biopsy will be obtained using an 18-gauge transjugular liver biopsy needle.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Endoscopic ultrasound portal pressure gradient measurement with liver biopsy
Description: A linear echoendoscope is inserted with the patient under conscious sedation. Using a through the scope 25-gauge needle connected to a digital manometer, portal and hepatic veins will be punctured under EUS guidance from a trans-gastric/hepatic approach. Following this, EUS-Liver biopsy is then performed immediately following EUS-PPG using a 19-gauge fine needle biopsy (FNB).
Study: NCT06369987

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Deleficon A (multifocal)
Description: Daily disposable silicone hydrogel contact lenses indicated for presbyopia, in addition to myopia or hyperopia.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Deleficon A (multifocal)
Description: Daily disposable silicone hydrogel contact lenses indicated for presbyopia, in addition to myopia or hyperopia.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Senofilcon A (multifocal)
Description: Daily disposable silicone hydrogel contact lenses indicated for presbyopia, in addition to myopia or hyperopia

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Senofilcon A (multifocal)
Description: Daily disposable silicone hydrogel contact lenses indicated for presbyopia, in addition to myopia or hyperopia
Study: NCT05327270

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nivolumab
Description: Given by IT
Study: NCT06554366

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: GentleWave
Description: Root canals will be shaped using a Vortex Blue and ProTaper gold rotary system. Once the root canals have been shaped, the GentleWave procedure will be performed

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: EdgePro laser irrigation
Description: Root canals will be shaped using a Vortex Blue and ProTaper gold rotary system. Once the root canals have been shaped, the EdgePro procedure will be performed

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Irrisafe passive ultrasonic irrigation
Description: Root canals will be shaped using a Vortex Blue and ProTaper gold rotary system. Once the root canals have been shaped, the passive ultrasonic irrigation procedure will be performed
Study: NCT06168175

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sodium lactate
Description: 2 mmol/kg, intravenous, daily for 5 consecutive days

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: intravenous, daily for 5 consecutive days
Study: NCT05488314

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Capmatinib
Description: Capmatinib will be administered orally.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Capmatinib
Description: Capmatinib will be administered orally.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Amivantamab
Description: Amivantamab will be administered as IV infusion.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Amivantamab
Description: Amivantamab will be administered as IV infusion.
Study: NCT05564052

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ibrutinib
Description: Ibrutinib capsules will be administered orally.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ibrutinib
Description: Ibrutinib capsules will be administered orally.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ibrutinib
Description: Ibrutinib capsules will be administered orally.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lenalidomide
Description: Lenalidomide capsules will be administered orally.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rituximab
Description: Rituximab will be administered IV.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rituximab
Description: Rituximab will be administered IV.
Study: NCT05995964

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PF-07264660
Description: subcutaneous injection

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PF-07264660
Description: subcutaneous injection

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Placebo
Description: subcutaneous injection

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Placebo
Description: subcutaneous injection
Study: NCT04842448

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen
Description: Hyperbaric oxygen 240 kPa for 90 minutes (with 10 min compression time, 2 air bakes and 10 minutes decompression time).

Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Sham treatment
Description: Sham treatment 134-120 kPa Air (with 5 min compression time, and 5 min decompression to 120 kPa, two air brakes will be reported to the subjects)
Study: NCT05762796

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: tDCS in Youth with mild traumatic brain injury
Description: The safety and tolerability of tDCS have been established in children with mTBI (1). A recent study of 13-18 year youths post-mTBI showed that three sessions of 1.5 mA anodal tDCS over the left DLPFC, positively influenced prolonged working memory deficits. (2) Additionally, rodent studies show the effectiveness of tDCS in improving cognitive-motor (motor planning and balance/gait) function in rats with mTBI. (3)